Source: International Congress 2017 – Techniques in biomarker selection
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Pignatti (Pavia, Italy). A rapid method to increase the clinical use of sputum inflammatory cells. 2937

Member's Comments

No comment yet.

Related content which might interest you: The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Clinical applications of assessment of airway inflammation using induced sputum Source: Eur Respir J 2002; 20: 40S-43S Year: 2002 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 A method to preserve sputum for delayed examination Source: Eur Respir J 2003 Dec 01;22(6):996-1000 Year: 2003 The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006 Sputum mast cells associate with clinical and inflammatory features of asthma Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 The new paradigm: assessing airway inflammation rather than diagnostic labelling is a movement not a fad Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006 How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 The use of induced sputum in clinical trials Source: Eur Respir J 2002; 20: 47S-50S Year: 2002 A comparison of sputum induction methods Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002 Sputum: ready for clinical applications? Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice Year: 2005 Airway inflammation: assessment of neutrophil apoptosis in induced sputum Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Clinical use of induced sputum in the management of asthma. A noninvasive measurements of airway Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007 Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma Source: ERJ Open Res, 6 (1) 00280-2019; 10.1183/23120541.00280-2019 Year: 2020 Increased apoptosis in induced sputum cells in stable COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007 Comparison of Nε-(carboxymethyl)lysine levels and percentage of eosinophils in induced sputum for assessment of small airway involvements in asthma Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Source: Eur Respir J 2003; 22: 484-490 Year: 2003 To compare the diagnostic accuracy of acid fast bacilli smear results of induced sputum with broncho-alveolar lavage among pulmonary tuberculosis cases keeping acid fast bacilli culture as gold standard in a resource limited setting in non expectorating patients Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 A proteomic approach to the progression of COPD: protein expression profile in induced sputum samples Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006